Caladrius Biosciences Closes The Sale Of Its Remaining Interest In PCT To Hitachi Chemical Co., Ltd. For $75 Million Post author:Sam Post published:May 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like AEterna Zentaris Announces Presentation Regarding Macrilen At 99th Annual Meeting Of March 2, 2017 Bavarian Nordic Rockets on Expanded $846 Million HIV-Hepatitis B Deal With Johnson & Johnson July 26, 2017 Genentech Shows Off Positive Results From Phase III HEMLIBRA, TECENTRIQ Studies November 19, 2017
Bavarian Nordic Rockets on Expanded $846 Million HIV-Hepatitis B Deal With Johnson & Johnson July 26, 2017